Oncology v 2

67
ONCOLOGY

description

Oncology v 2

Transcript of Oncology v 2

Page 1: Oncology v 2

ONCOLOGY

Page 2: Oncology v 2

Wh

at Is Can

cer?

Page 3: Oncology v 2

CANCER DIAGNOSIS

• The term “Cancer” has been use todescribe over 100 different diseasescharacterized by uncontrolled cellgrowth

Page 4: Oncology v 2

WARNINGS SIGNS

• Weight loss

• Persistent Fever

• Fatigue

• Sores

• Bowel patterns

• Pain

• Indigestion

• Lump

• Unusual bleeding

Page 5: Oncology v 2

Different Kinds of Cancer

Some commoncarcinomas:

Lung

Breast (women)

Colon

BladderProstate (men)

Leukemias:Bloodstream

Lymphomas:Lymph nodes

Some commonsarcomas:Fat

Bone

Muscle

Artwork by Jeanne Kelly. © 2004.

Page 6: Oncology v 2

Naming Cancers

Cancer Prefixes Point to LocationPrefix Meaning

adeno-

chondro-

erythro-

hemangio-

hepato-

lipo-

lympho-

melano-

myelo-

myo-

osteo-

gland -

cartilage -

red blood cell

blood vessels

liver -

fat-

lymphocyte

pigment cell

bone marrow

muscle -

bone -

Page 7: Oncology v 2

Loss of Normal Growth Control

Normalcell division

Cell Suicide or Apoptosis

Cell damage-no repair

Cancercell division

First Secondmutation mutation

Third Fourth ormutation later mutation

Uncontrolled growth

Art

wor

k by

Jea

nne

Kel

ly. ©

200

4.

Page 8: Oncology v 2

Malignant versus Benign Tumors

Benign (not cancer)tumor cells growonly locally and cannotspread by invasion ormetastasis

Malignant (cancer)cells invadeneighboring tissues,enter blood vessels,and metastasize todifferent sites

___ Jjaa

Time

Art

wor

k by

Jea

nne

Kel

ly. ©

200

4.

Page 9: Oncology v 2

Why Cancer Is Potentially Dangerous

Brain

LiverMelanoma

(initial tumor)

Artwork by Jeanne Kelly. © 2004.

Melanomacells travelthroughbloodstream

Page 10: Oncology v 2
Page 11: Oncology v 2

PROPERTIES OF CANCER CELLS

* Growth without “go” (positive) signals

* Failure to respond to “stop” (negative) signals

* Evasion of programmed cell death (apoptosis)

* Unlimited cell division

* Sustained angiogenesis (stimulation of blood

vessel growth)

* Tissue invasion and metastasis

Page 12: Oncology v 2

GROWTH WITHOUT “GO”(POSITIVE) SIGNALS

* Growth factors

* Oncogene

Page 13: Oncology v 2

FAILURE TO RESPOND TO “STOP”(NEGATIVE) SIGNALS

• Contact inhibition

Tumour suppressor genes

Page 14: Oncology v 2

EVASION OF PROGRAMMED CELLDEATH (APOPTOSIS)

• Death signals

p53

Page 15: Oncology v 2

UNLIMITED CELL DIVISION

* Telomeres

Telomerases

Page 16: Oncology v 2

SUSTAINED ANGIOGENESIS(STIMULATION OF BLOOD VESSEL

GROWTH)

• VEGF (Vascular Endothelial GrowthFactors)

Nutrient, oxygen

Page 17: Oncology v 2

TISSUE INVASION AND METASTASIS

* 90% of cell death due to single cellmutation

Migration

Page 18: Oncology v 2

COMMON DIAGNOSTIC TESTS

• Blood test

• Imaging test

• Biopsy

• Cancer Staging

Page 19: Oncology v 2

BLOOD TESTS

• Tumour markers - protein that arefound to be elevated in certaincancer

Use to check for treatment response

Page 20: Oncology v 2

BLOOD TESTS

* Examples includes:

* CA125 for Ovarian Cancer (protein produced

when abdominal tissues are inflamed)

* PSA also known as Prostate specific antigen for

Prostate cancer(protein produce by prostate

cells, when too many will increase)

* AFP also known as alpha fetoprotein for liver

cancer (protein produce by liver tumours but

also elevate in hepatitis)

Page 21: Oncology v 2

IMAGING

• X rays, ultrasound to create image of

internal structures

• CT scan (multiple X rays to form 3D

image)

• MRI also known as magnetic resonance

imaging use magnetic field to create

image

Page 22: Oncology v 2

BIOPSY

• Removal of small piece of tissue from

patient

* Expert to look at microscopic images,

check for tumour markers or DNA

mutations

Page 23: Oncology v 2

CANCER STAGING

* After diagnosis have been made, staging

perform to determine the extend of the disease

progression and evaluate the best treatments

* T: 1-4 For size of tumour(Larger number indicate

larger tumours and spread

* N 0-2 For presence of tumour in lymph nodes

(Larger number indicate spread)

•Ml given to metastases (0 indicate not

spreading)

Page 24: Oncology v 2

Cancer Detection and Diagnosis

Art

wor

k by

Jea

nne

Kel

ly. ©

200

4.

Page 25: Oncology v 2

Early Cancer May Not Have Any Symptoms

Art

wor

k by

Jea

nne

Kel

ly. ©

200

4.

Page 26: Oncology v 2

Cervical Cancer Screening

NormalPap smear

AbnormalPap smear

Page 27: Oncology v 2

Breast C

ancer Screening

Page 28: Oncology v 2
Page 29: Oncology v 2

Colon Cancer Screening

Art

wor

k by

Jea

nne

Kel

ly. ©

200

4.

Page 30: Oncology v 2

Art

wor

k by

Jea

nne

Kel

ly. ©

200

4.

Biopsy

or blood sample Genomic profile

Page 31: Oncology v 2

Microscopic Appearance of Cancer Cells

Normal Cancer

Large number of irregularlys^aPec* div'd'ng cells

a Large, variably shaped nuclei

a Small cytoplasmic volumerelative to nuclei

Variation in cell size and shape

Loss of normal specializedcell features

^ Disorganized arrangement

Poorly defined tumor boundary

2004

.

Page 32: Oncology v 2

Tumor Grading

100%

General Relationship BetweenTumor Grade and Prognosis

PatientSurvival

Rate

Low grade

High grade

Years

Page 33: Oncology v 2

Tumor Staging

100%

50%

Five-Year Survival Rates forPatients with Melanoma (by stage)

I II III

Stage at Time of Initial Diagnosis

Art

wor

k by

Jea

nne

Kel

ly. ©

200

4.

Page 34: Oncology v 2

What Causes Cancer?

Some viruses or bacteria

Some chemicals Radiation

Artwork by Jeanne Kelly. © 2004.

Page 35: Oncology v 2

ROLES OF DNA DAMAGE ANDMUTATION

• Radiation

• Chemicals

• Environmental toxins

Others

Page 36: Oncology v 2

RADIATION

• Examples such as: X rays, CT scan, UV,

radon (radioactive gas)

* Production of Free radicals - atoms with

unpaired electrons

* Antitoxin such as some vitamins

Page 37: Oncology v 2

CHEMICALS AND ENVIRONMENTAL

TOXINS

• Chemicals such as mustard gas,hair dyes, chemotherapy drugs

• Environmental toxins such as tarfrom cigarette, coal etc

Page 38: Oncology v 2

OTHERS

• Virus such as oncoviruses examples Epstein-Barr virus(EBV), Human papillomavirus (HPV), mouse mammarytumour virus (MMTV)

• Specific virus to cancer types

• Hepatitis B,C (Liver Cancer)

• HPV (Cervical Cancer)

• EBV (Lymphatic Cancer)• Kaposi sarcoma herpes virus (Kaposi sarcoma skin

cancer)

• Human T lymphotrophic Virus 1 (T cell leukemia)

Page 39: Oncology v 2

Viruses

Virus insertsand changesgenes forcell growth

Cancer-linked virus

Art

wor

k by

Jea

nne

Kel

ly. ©

200

4.

Page 40: Oncology v 2

Examples of Human Cancer Viruses

Some Viruses Associated with Human Cancers

Virus Type of Cancer

Epstein-Barr virus Burkitt’s lymphoma

Human papillomavirus Cervical cancer

Hepatitis B virus Liver cancer

Human T-celllymphotrophic virus

Adult T-cell leukemia

Kaposi’s sarcoma-associated herpesvirus

Kaposi’s sarcoma

Art

wor

k by

Jea

nne

Kel

ly. ©

200

4.

Page 41: Oncology v 2

AIDS and Kaposi’s Sarcoma

Art

wor

k by

Jea

nne

Kel

ly. ©

200

4.

Page 42: Oncology v 2

Bacteria and Stomach Cancer

Artwork bv can c Koiiy. 2004 Patient’s tissue H. pylorisample

Page 43: Oncology v 2

Heredity and Cancer

■ Inherited factor(s)■ Other factor(s)

Art

wor

k by

Jea

nne

Kel

ly. ©

200

4.

Page 44: Oncology v 2

Heredity Can Affect Many Types of Cancer

Inherited Conditions That Increase Risk for Cancer

Name of Condition Type of Cancer

Hereditary retinoblastoma Retinoblastoma

Xeroderma pigmentosum Skin

Wilms’ tumor KidneyLi-Fraumeni syndrome Sarcomas, brain, breast,

leukemia

Familial adenomatouspolyposis

Colon, rectum

Paget’s disease of bone Bone

Fanconi’s aplastic anemia Leukemia, liver, skin

Art

wor

k by

Jea

nne

Kel

ly. ©

200

4.

Page 45: Oncology v 2

Genetic Testing

Page 46: Oncology v 2

Cancer Risk and Aging

Number ofCancer Cases(per 100,000

people)

Cancer Risk and Aging400

300

200

100

0 20 40 60 80

Age of Person (in years)

Page 47: Oncology v 2

DNA Mutation

Normal gene

C G A A C T

Single base change

Deletions

Page 48: Oncology v 2

Normal cell

Cancer cell

Oncogenes

Mutated/damaged oncogene

Art

wor

k by

Jea

nne

Kel

ly. ©

200

4.

Page 49: Oncology v 2

Proto-Oncogenes and Normal Cell Growth

Normal Growth-Control Pathway

Growth factor

Receptor

Cell nucleus

0 Signaling enzymes

Transcriptionfactors

DNA

ell t

Cell proliferatio

Page 50: Oncology v 2

Oncogenes areMutant Forms of Proto-Oncogenes

Inactive growth factor receptor Inactive intracellularsignaling protein

Signaling protein from active oncogene

Cell proliferation driven byinternal oncogene signaling

Art

wor

k by

Jea

nne

Kel

ly. ©

200

4.

Page 51: Oncology v 2

Normalgenes

preventcancer

Remove or inactivate tumorsuppressor genes

Damage toboth genesleads tocancer

Normal cell

Page 52: Oncology v 2

Tumor Suppressor GenesAct Like a Brake Pedal

Growth factor

Receptor

Cell nucleus

Tumor Suppressor

Art

wor

k by

Jea

nne

Kel

ly. ©

200

4.

Page 53: Oncology v 2

p53 Tumor Suppressor ProteinTriggers Cell Suicide

Normal cell Excessive DNA damage Cell suicide(Apoptosis)

Art

wor

k by

Jea

nne

Kel

ly. ©

200

4.

Page 54: Oncology v 2

Base pairmismatch

Page 55: Oncology v 2

Cancer Tends to Involve Multiple Mutations

Benign tumor cells Malignant cells invadegrow only locally and neighboring tissues, entercannot spread by blood vessels, and metastasize

to different sitesinvasion or metastasis

Time

Mutation Cells Mutations Proto-oncogenes More mutations,inactivates proliferate inactivate mutate to oncogenes more geneticsuppressor DNA repair instability,gene genes metastatic

disease

Art

wor

k by

Jea

nne

Kel

ly. ©

200

4.

Page 56: Oncology v 2

Mutations and Cancer

Genes Implicated in CancerThe prime suspects But

Mutations in: Other mutations also occur in:

Oncogenes Cell death genes

■ Tumor suppressor genes Cell signaling genes

■ DNA repair genes Cell cycle checkpoint genes

Cellular senescence genes

■ Cellular differentiation genes

■ Metastasis/invasion genes

Carcinogen-activating genes-deactivating genes A

rtw

ork

by J

eann

e K

elly

. © 2

004.

Page 57: Oncology v 2

Cancer Tends toCorrupt Surrounding Environment

Blood vessel Cytokines!

Growth factors = proliferationInvasive

Matrix

Fibroblasts,adipocytes

Cytokines, proteases = migration & invasion

Art

wor

k by

Jea

nne

Kel

ly. ©

200

4.

Page 58: Oncology v 2

TREATMENTS

* Surgery

* Radiation

* Chemotherapy

* Others

Page 59: Oncology v 2

SURGERY

• Removal of solid cancerous tumour as

much as possible

* Exception include blood cancer such as

leukaemia

Page 60: Oncology v 2

RADIATION

* Use of high energy waves to kill or inhibit cell

division

* External beam or seed radioactive within the

tumour

* Trigger apoptosis due to DNA damage but affects

normal cells

Page 61: Oncology v 2

CHEMOTHERAPY

* Use of drugs to treat cancer

* Side effects include hair loss, nausea

* Damage DNA

* Interfere with DNA replication

* Interfere with cell division

Page 62: Oncology v 2

CHEMOTHERAPY

* Cisplatin (Platinol) for DNA damage

* Doxorubicin (Adriamycin) for DNA

damage

* 5 fluorouracil (Efudex, Adrucil) inhibit

DNA replication* Paclitaxel (Taxol) inhibit mitosis

* Vinblastine (Velban) inhibit mitosis

Page 63: Oncology v 2

OTHERS

• Bone marrow Transplantation

• Targeted Therapies

• Tumour Vaccines

• Gene Therapy

Page 64: Oncology v 2

BONE MARROW TRANSPLANTATION

• Leukaemia

• Lymphoma

• Stem cells are often damage after

chemotherapy and radiation

• Taken before patient and put back after

treatment

Page 65: Oncology v 2

TARGETED THERAPIES

• Pharmacogenomics

• Specialized treatment based onhuman genetics

• Fewer side effects

Page 66: Oncology v 2

TUMOUR VACCINE

• Prevent infection example from oncovirus

* Gardasil for cervical cancer as it target

HPV

Page 67: Oncology v 2

GENE THERAPY

* Introduction of DNA to allow protein to be

made to overcome disease• P53

Clinical Trails